Skip to main content
. 2021 Sep 1;11:675533. doi: 10.3389/fonc.2021.675533

Table 2.

Univariate and multivariate survival analysis for OS.

Univariate Multivariate
HR (95% CI for HR) p.value HR (95% CI for HR) p.value
Histological Grade 1.7 (1.0–2.8) 0.037 * *
Clinical stage 4 (2.5–6.3) 2.10E-09 3.6550 (2.3062–5.7926) 3.46e-08
Age 0.73 (0.42–1.3) 0.26 * *
Angioma thrombus 1.3 (0.77–2.3) 0.3 * *
Lymph node status 3.2 (1–10) 0.049 * *
RCB class 3.3 (1.9–5.8) 2.50E-05 2.1608 (1.1393–4.0981) 0.01831
ER 0.89 (0.49–1.6) 0.69 * *
PR 0.9 (0.51–1.6) 0.7 * *
KI67 2.4 (0.85–6.5) 0.1 * *
HER2 0.5 (0.26–0.98) 0.044 0.4322 (0.2186–0.8548) 0.01592
Tils 0.28 (0.17–0.46) 3.20E-07 0.2128 (0.1152–0.3931) 7.72e-07
MP class 0.65 (0.46–0.91) 0.013 * *
Mitosis 1.4 (0.82–2.3) 0.23 * *
Molecular 1 (0.69–1.5) 0.86 * *

*Not statistically significant.